Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

Merck to acquire Prometheus Biosciences for $10.8B

The acquisition is one of 2023's biggest healthcare deals so far.

Thumbnail

Sanofi’s $2.9B acquisition of Provention Bio delayed by FTC review

According to Sanofi, it has withdrawn and refiled its premerger notification and report form with the FTC to give the agency more time to review the deal.

Private equity in healthcare: Deals decreased in 2022, but market was still active

"Healthcare private equity has earned a recession-proof reputation," according to one expert. 

mergers and acquisitions M&A puzzle

Radiologists now operating under UnitedHealth ownership after industry giant buys prominent practice

“Crystal Run has long recognized that the fee-for-service reimbursement model is broken," the practice's CEO said in an email to employees.

Thumbnail

Medtronic, DaVita launch new kidney health company

"Mozarc Medical's focus will be on meaningful and innovative kidney health technologies that improve the overall patient experience and increase access to care globally," CEO Ven Manda said. 

board room table trustee directors

Cano Health leadership team in disarray after directors resign

Billionaire Barry Sternlicht, founder and CEO of Starwood Capital Group, was one of the board members who resigned.

private equity corporatization business consolidation

Expert panel: Radiologists with MBAs weigh in on private equity’s entrée into imaging

Three members of the specialty recently offered advice to leaders navigating this issue in their organization. 

Thumbnail

Illumina ordered to divest Grail

The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.